Monalisa Hard + Lidocaine

Monalisa Hard Lidocaine is an ultra-pure, high-density cross-linked hyaluronic acid dermal filler developed by Genoss, engineered specifically for deep structural volumization, severe soft tissue deficit correction, and distinct facial contouring. Utilizing advanced Hy-Bi (Hybrid Biphasic) technology, this premium medical-grade injectable features a highly cohesive, tightly packed uniform particle structure. This high-density formulation delivers exceptional mechanical lifting power and an elite elastic modulus (high G prime), allowing the gel to maintain robust structural projection under the pressure of dense facial muscle layers without flattening or migrating from the injection site.

Formulated with integrated 0.3 percent lidocaine hydrochloride to mitigate patient discomfort and optimize clinical execution, Monalisa Hard is the premier backbar asset for building foundational skeletal definition. It is explicitly indicated for deep subcutaneous or supraperiosteal placement to execute malar (cheek) augmentation, mandibular (jawline) remodeling, pre-jowl sulcus correction, and distinct chin projection. The highly cross-linked, non-animal derived HA matrix undergoes a rigorous purification process to minimize residual chemical cross-linkers, ensuring excellent tissue bio-compatibility and a stable, long-lasting volumetric retention lifespan of 12 to 14 months.

Monalisa Hard Lidocaine provides aesthetic medical professionals with a highly predictable, structurally stable clinical asset engineered to reconstruct volume loss, sharpen facial profiles, and deliver durable, high-definition rejuvenation.

Key Benefits:

High Density Particle Matrix: Specialized uniform particle engineering provides superior mechanical support and structural resistance to lateral tissue migration.
Elite Structural Lifting Power: Engineered to deliver maximum volumetric projection and distinct bone-mimicking contours in deep facial planes.
Integrated Local Anesthetic: Features 0.3 percent lidocaine hydrochloride to reduce manual extrusion force and enhance intraoperative patient compliance.
Ultra Low Residual Impurities: Strict post-link washing processes minimize chemical remnants, lowering the incidence of late-stage inflammatory responses.
Extended Volumetric Longevity: Highly cross-linked molecular network resists early enzymatic breakdown, maintaining firm facial definition for up to 14 months.

Product Specifications and Packaging:

Volume: 1 x 1ml sterile, prefilled glass syringe.
Concentration: 20 mg/ml cross-linked sodium hyaluronate + 0.3 percent lidocaine hydrochloride.
Injection Depth: Deep dermis, subcutaneous, or supraperiosteal layers.
Package Components: 1 x 1ml prefilled syringe, 2 x sterile 25G 1/2 needles.
Classification: CE marked medical device intended for professional clinical use only.

Usage:

For professional use only. Must be administered via deep bolus, linear threading, or fanning techniques into the deep subcutaneous or supraperiosteal layers by qualified, trained medical practitioners utilizing strict sterile clinical protocols.